Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Theravance Biopharma (TBPH) Long-Term Debt Repayments (2020 - 2021)

Historic Long-Term Debt Repayments for Theravance Biopharma (TBPH) over the last 2 years, with Q2 2021 value amounting to $5.0 million.

  • Theravance Biopharma's Long-Term Debt Repayments changed N/A to $5.0 million in Q2 2021 from the same period last year, while for Dec 2022 it was $5.0 million, marking a year-over-year decrease of 5310.34%. This contributed to the annual value of $400.0 million for FY2022, which is 362784.72% up from last year.
  • Latest data reveals that Theravance Biopharma reported Long-Term Debt Repayments of $5.0 million as of Q2 2021.
  • Theravance Biopharma's 5-year Long-Term Debt Repayments high stood at $235.3 million for Q1 2020, and its period low was $5.0 million during Q2 2021.